Sai Life Sciences Limited has formally submitted the transcript for its recent Earnings Call, which discussed the Unaudited Financial Results for the quarter and nine months ending 31 December 2025. The call took place on Friday, 6 February 2026. Investors and stakeholders can now access the full details of the discussions on the company’s official website, providing comprehensive insight into the performance leading up to the end of the third quarter of the fiscal year 2025-2026.
Disclosure of Financial Discussion
Sai Life Sciences Limited has completed the regulatory requirement of disseminating the official transcript of its recent Earnings Call. This call focused specifically on the Unaudited Financial Results announced for the company covering the period ending 31 December 2025.
Earnings Call Details
The investor conference regarding the financial performance for the quarter and the nine months ended December 31, 2025, was held on Friday, 6 February 2026, commencing at 04:00 PM (IST).
Transcript Availability
As per the notification issued on 13 February 2026, the complete transcript document has been made available to the public. Stakeholders interested in reviewing the detailed discussions and management commentary can find the file named Earnings-Call-Transcript-Q3-FY26.pdf uploaded on the company’s official website.
The document confirms the submission by Runa Karan, the Company Secretary & Compliance Officer.
Source: BSE
